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DObjective: Acute renal failure after valve surgery carries significant morbidity and mortality. Preoperative car-
diac catheterization is the standard of care. For convenience, catheterization just before surgery is simplest for
patients. However, it is not known if this timing of radiocontrast administration significantly affects renal func-
tion. We hypothesized that preoperative cardiac catheterization within 24 hours of valve surgery is associated
with the development of acute renal failure.
Methods: A retrospective case-control study was performed of all patients undergoing valve surgery between
2003 and 2008 at the University of Virginia. Patients with preoperative renal dysfunction were excluded. Patients
with postoperative acute renal failure were matched to those without acute renal failure according to age, gender,
year of surgery, New York Heart Association functional class, elective status, concomitant coronary artery bypass
grafting, and type of valve procedure. A logistic regression model examined the effects of perioperative risk fac-
tors on the development of acute renal failure.
Results: Of 1287 patients undergoing valve surgery, 61 with acute renal failure were matched to 136 without
acute renal failure. Cardiac catheterization within 24 hours of surgery was significantly greater in patients with
acute renal failure (31.2% vs 8.8%, P ¼ .013). The risk of acute renal failure was more than 5 times higher
for patients undergoing catheterization within 24 hours of surgery (odds ratio, 5.3; P¼ .004). The number of post-
operative vasopressors was significantly associated with acute renal failure (odds ratio, 1.7; P ¼ .007).
Conclusions:Although catheterization is often performed for patient convenience, catheterizationwithin 24 hours
of valve surgery is significantly associated with the development of acute renal failure. Current practices should
be adjusted to ensure that more than 24 hours have passed from the time of cardiac catheterization to valve surgery
in elective settings. (J Thorac Cardiovasc Surg 2010;140:1011-7)Acute renal failure (ARF) is a serious and unfortunately com-
mon complication after cardiac surgery occurring in up to 30%
of patients.1-6 Furthermore, valvular heart surgery is an
independent risk factor for ARF, conferring a 2.7-fold
increased risk compared with coronary artery bypass grafting
(CABG) alone.7 Contrast-induced nephropathy accounts for
a significant number of cases of hospital-acquired ARF,8-10
and ARF is associated with a 20% mortality rate after
cardiac catheterization.11,12 Previous studies have suggested
a temporal relationship between the timing of cardiace Department of Surgery, University of Virginia, Charlottesville, Va.
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The Journal of Thoracic and Carcatheterization and the development of ARF in patients
undergoing CABG and combination cardiac procedures.13-15
It is unclear whether timing of radiocontrast administra-
tion for cardiac catheterization significantly affects renal
function after heart valve surgery. Elective cardiac catheter-
ization is often performed the day before surgery for con-
venience. We hypothesized that preoperative cardiac
catheterization within 24 hours of heart valve surgery is
associated with the development of ARF.MATERIALS AND METHODS
Data Source and Patient Population
Approval for this investigation was obtained from the human investiga-
tion committee of the University of Virginia Health System, including
a waiver of the need to obtain patient consent. All patients undergoing car-
diac surgery at the University of Virginia were prospectively entered into
the Society of Thoracic Surgeons (STS) database.
A retrospective review was performed of all patients who underwent
heart valve surgery (repair or replacement) from August 2003 to December
of 2008. The 1287 patients identified were stratified as those with postoper-
ative ARF (ARF group) and without postoperative ARF (no ARF group).
All patients with preoperative renal failure or renal dysfunction were
excluded from the study.
Variables Examined and Outcomes Measured
Renal failure or dysfunction was defined on the basis of accepted STS
definitions.16 Postoperative ARFwas defined as any patient with an increasediovascular Surgery c Volume 140, Number 5 1011
Abbreviations and Acronyms
ARF ¼ acute renal failure
CABG ¼ coronary artery bypass grafting
CI ¼ confidence interval
CPB ¼ cardiopulmonary bypass
OR ¼ odds ratio
STS ¼ Society of Thoracic Surgeons
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Dof serum creatinine to greater than 2.0 mg/dL and 2 times the most recent
preoperative creatinine level or the requirement for dialysis postoperatively.
Preoperative renal failure or dysfunction was defined as a documented his-
tory of renal failure, a history of a creatinine level greater than 2.0 mg/dL, or
the need for current dialysis.
Patient demographic characteristics, preoperative risk factors, operative
features, and postoperative outcomes were examined. STS definitions were
used to describe all preoperative variables, postoperative complications, and
outcomes.16 In this population, epinephrine was commonly used during low
cardiac output and norepinephrine/vasopressin/phenylephrine was used for
a vasoplegic state. Mortality was defined as any patient death that occurred
before hospital discharge or within 30 days of operation. A major complica-
tion included the composite incidence of postoperative stroke, mortality,
infection, and prolonged ventilation. Timing of cardiac catheterization to
surgery was defined as less than 24 hours, 24 to 48 hours, 48 to 72 hours,
and greater than 72 hours. The following postoperative vasopressor admin-
istration was recorded for each patient during the first 6 hours after surgery:
epinephrine, norepinephrine, vasopressin, and phenylephrine. Each pa-
tient’s preoperative hemoglobin (grams/deciliter) and lowest intraoperative
hemoglobin (grams/deciliters) were collected and subsequently used to cal-
culate change in intraoperative hemoglobin (grams/deciliters). In addition,
the highest rewarming temperature (degrees Celsius) was recorded for
each patient after cardiopulmonary bypass (CPB).
The primary end point was the development of ARF after heart valve
surgery. The influence of perioperative variables on the development of
ARF was studied.
Statistical Analysis
A case-control study was performed on the 1287 patients who underwent
heart valve surgery. Patients with ARF were matched to patients without
ARF according to age, gender, year of surgery, NewYorkHeart Association
functional class, elective versus emergent/urgent operative status, con-
comitant CABG, and type of valve procedure (aortic, mitral, tricuspid,
and pulmonic valves). Year of surgery was matched to within 1 year, and
age of the patient at the time of surgery was matched to within 5 years.
Case-control matching was performed using Bergstralh and colleagues’ al-
gorithm.17 Up to 3 controls were matched to each case in the study popula-
tion to maximize the balance achieved across criteria in the available
population.18 The adequacy of the balance achieved between cases and con-
trols was formally assessed using the chi-square test statistic for all categoric
matching criteria and the t test statistic to assess the significance of the
difference in mean age.
Patient demographic, preoperative risk factors, operative features, and
postoperative outcomeswere comparedusing a univariate analysis.Categoric
variables were compared using the chi-square or Fisher’s exact test where
appropriate. Continuous variables were compared using a 2-sided t test.
A multivariable conditional logistic regression was performed to assess
the statistical significance of the association between ARF and a series of
exposures of interest.19 The following variables were entered as covariates:
preoperative angiotensin-converting enzyme inhibitor or angiotensin II re-
ceptor blocker use, timing of cardiac catheterization before surgery (within
24 hours, 24–48 hours, 48–72 hours, or72 hours), intraoperative aprotinin1012 The Journal of Thoracic and Cardiovascular Suruse, number of postoperative vasopressors, lowest intraoperative hemoglo-
bin, change in hemoglobin, and highest CPB rewarming temperature and
CPB time. These covariates were chosen a priori on the basis of the literature
and clinical knowledge. CPB time was significantly different between the
ARF and no ARF groups and therefore included in the logistic regression
to account for that difference. Other established risk factors for ARF (age,
diabetes, degree of heart failure, urgent/emergent operative status) were
controlled for in the case-control analysis. Patients in the ARF group and
the no ARF group were equal according to these established risk factors
and therefore not included in the multivariable analysis.
Conditional logistic regression was performed using the discrete logistic
form of the Cox proportional hazards model with strata formed for each
matched set. Cases and controls were compared and assessed for significant
differences on each exposure of interest using the Wald chi-square test sta-
tistic. The magnitude of differences in renal failure complications for each
exposure was measured by calculating odds ratios (ORs), and 95% confi-
dence intervals (CI) were calculated to assess the statistical significance
of the difference in odds between cases and controls. Data manipulation
and analysis were performed with SAS version 9.1.3 software (SAS
Institute, Inc, Cary, NC)
RESULTS
From August 2003 to December 2008, 1287 patients un-
derwent heart valve surgery at the University of Virginia. Of
this cohort, 83 patients (6.6%) had postoperative ARF and
52% of these patients required dialysis. Records for patients
without ARF were searched to find patients of identical age,
gender, New York Heart Association functional class,
elective status or emergent/urgent operative status, concom-
itant CABG, year of surgery, and type of valve procedure. A
total of 61 patients with ARF were matched to 136 patients
without ARF, with 61 cases matched to at least 1 control, 44
cases matched twice, and 31 cases matched to 3 controls. Of
the 83 patients with ARF, 22 were excluded from the study
because there was no suitable match to a patient without
ARF according to our matching criteria.
Preoperative Risk Factors and Operative Features
As seen in Table 1, balance was achieved across all
matching criteria, such that no statistically significant differ-
ences were observed in the proportional distributions or
mean values of the matching covariates. The number of pa-
tients in the ARF group was equal to the number of patients
in the no ARF group according to elective versus emergent/
urgent operative status (emergent/urgent status: 41% vs
37.5%, P ¼ .76).
Preoperative creatinine was not significantly different
between the ARF and no ARF groups (1.21  0.04 mg/dL
vs 1.12  0.02 mg/dL, P ¼ .06). Preoperative risk factors in
patients with ARF were equivalent to patients without ARF
(Table 2). There was no statistically significant difference in
STS-predicted risk between patients with and without ARF
(8% 8% vs 6% 6%, P¼ .31). There was no difference
in diabetes (24% vs 30.2%,P¼ .42), hypertension (73.8% vs
72.1%,P¼ .80), or dyslipidemia (68.9% vs 66.9%,P¼ .79).
Patients with ARF differed from patients without ARF on
several perioperative factors (Table 3). Patients with ARFgery c November 2010
TABLE 1. Summary of matching criteria for patients with and
without acute renal failure
ARF
(n ¼ 61) (%)
No ARF
(n ¼ 136) (%)
P
value*
Age at operation
(y, mean  SD)
67  13.9 67.7  13.7 .77
Male 29 (47.5%) 68 (50.0%) .75
Year of surgery .61
2003 2 (3.3%) 3 (2.2%)
2004 5 (8.2%) 17 (12.5%)
2005 10 (16.4%) 13 (9.6%)
2006 6 (9.8%) 21 (15.4%)
2007 18 (29.5%) 38 (27.9%)
2008 20 (32.8%) 44 (32.4%)
NYHA functional class .92
1 23 (37.7%) 55 (40.4%)
2 7 (11.5%) 18 (13.2%)
3 12 (19.7%) 22 (16.2%)
4 19 (31.2%) 41 (30.2%)
Operative status .76
Elective surgery 36 (59.0%) 85 (62.5%)
Emergent/urgent surgery 25 (41.0%) 51 (37.5%)
CABG 25 (41.0%) 58 (42.7%) .83
Type of valve surgery
(repair or replacement)
Aortic 42 (68.9%) 100 (73.5%) .50
Mitral 20 (32.8%) 37 (27.2%) .42
Pulmonic 1 (1.6%) 1 (0.74%) .56
Tricuspid 3 (4.9%) 5 (3.7%) .68
ARF,Acute renal failure;NYHA,NewYork Heart Association;CABG, coronary artery
bypass grafting. *Significance< .05.
TABLE 2. Preoperative risk factors for patients with and without
acute renal failure after valve surgery
ARF
(n ¼ 61) (%)
No ARF
(n ¼ 136) (%)
P
value*
Ethnicity .73
Caucasian 58 (96.7%) 123 (94.0%)
African-American 2 (3.3%) 8 (6.1%)
History of tobacco 25 (41.0%) 57 (41.9%) .90
Dyslipidemia 42 (68.9%) 91 (66.9%) .79
Peripheral artery disease 10 (16.7%) 16 (11.8%) .37
Cerebrovascular disease 12 (20.0%) 29 (21.2%) .79
Chronic lung disease 10 (16.4%) 27 (19.9%) .57
Previous CVA 9 (14.8%) 17 (12.5%) .67
Diabetes 15 (24.0%) 41 (30.2%) .42
Hypertension 45 (73.8%) 98 (72.1%) .80
Preoperative creatinine
(mg/dL, mean  SD)
1.21  0.02 1.12  0.04 .06
ACE inhibitor/ARB use 23 (37.7%) 55 (40.4%) .72
Immunosuppressive
Medication
5 (8.2%) 10 (7.4%) .78
Previous CABG 5 (8.2%) 11 (8.1%) 1
Previous valve procedure 6 (9.8%) 15 (11.0%) .80
Arrhythmia 15 (25.6%) 37 (27.2%) .70
Angina 14 (23.0%) 39 (28.7%) .40
Heart failure 33 (54.1%) 59 (43.4%) .16
ARF, Acute renal failure; CVA, cerebrovascular accident; ACE, angiotensin-
converting enzyme inhibitor; ARB, angiotensin II receptor blocker; SD, standard
deviation; CABG, coronary artery bypass grafting. *Significance< .05.
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24 hours from the time of surgery (31.2% vs 8.8%,
P < .0001). CPB time was longer in the ARF group
(156.2  73.4 minutes vs 133.7  46.4 minutes, P ¼ .03).
In the first 6 postoperative hours, patients with ARF were
more likely to receive norepinephrine (61.7% vs 38.7%,
P ¼ .002) and vasopressin (60% vs 37.3%, P ¼ .003).
Association Between Acute Renal Failure and
Postoperative Outcomes
After valve surgery, patients with ARF had significantly
worse postoperative complications compared with patients
without ARF. Patients with ARF were more likely to un-
dergo reoperation secondary to postoperative bleeding or
tamponade (16.4% vs 5.9%, P ¼ .02). These patients
were also more likely to have postoperative sepsis, pneumo-
nia, a gastrointestinal complication, and noncardiac reoper-
ation (Table 4). ARF was associated with prolonged
ventilation (68.3% vs 16.2%, P< .0001), longer intensive
care unit stays (384.7  444.3 hours vs 79.2  72.7 hours,
P < .0001), and longer length of stays in the hospital
(24.3  21.3 days vs 8  4.8 days, P< .0001).
Overall major complication rates were significantly
higher in patients with acute ARF (20% vs 5.1%,The Journal of Thoracic and CarP ¼ .003). The 30-day mortality was significantly higher
in patients with ARF (18.3% vs 5.1%, P ¼ .004).
Risk Factors for Acute Renal Failure
The logistic regression identifies 2 risk factors associated
with the development of postoperative ARF (Table 5). The
risk of ARF was more than 5 times higher for patients
who underwent cardiac catheterization within 24 hours of
their valve surgery compared with patients who underwent
cardiac catheterization more than 72 hours before valve sur-
gery (OR, 5.3; CI, 1.9–15.2; P ¼ .004). The administration
of vasopressors in the first 6 postoperative hours was also
significantly associated with the development of ARF. The
risk of ARF increased 2-fold for every additional vasopres-
sor given (OR, 1.7; CI, 1.2–2.4; P ¼ .007).
DISCUSSION
ARF is a potentially devastating complication after heart
valve surgery. It is often associated with a complicated clin-
ical course and holds significant morbidity for patients, with
increased resource use, longer hospital stays, and increased
risk of infection. Patients requiring dialysis have exception-
ally high mortality rates ranging from 20% to 64%,3,20,21
and even small increases in serum creatinine are associated
with an increase in 30-day mortality.22
In this study, ARF developed in 6.6% of patients under-
going valve surgery with no history of renal dysfunction,diovascular Surgery c Volume 140, Number 5 1013
TABLE 3. Perioperative features for patients undergoing valve
surgery
ARF
(n ¼ 61) (%)
No ARF
(n ¼ 136) (%)
P
value*
STS predicted risk
(mean  SD)
8  8.0% 6  6.0% .31
IABP 8 (13.1%) 11 (8.1%) .27
Cardiac catheterization
within 24 h
19 (31.2%) 12 (8.8%) <.0001*
Cardiac catheterization
within 24–48 h
2 (3.3%) 25 (18.4%) .003*
Cardiac catheterization
within 48–72 h
7 (11.5%) 8 (5.9%) .24
Cardiac catheterization
>72 h before
33 (54.1%) 90 (66.2%) .11
CPB time (min, mean  SD) 156.2  73.4 133.7  46.4 .03*
Aprotinin 17 (27.9%) 24 (17.7%) .10
Epinephrine 50 (80.0%) 102 (74.3%) .24
Norepinephrine 37 (60.7%) 53 (39.0%) .005*
Vasopressin 37 (60.7%) 50 (36.8%) .002*
Phenylephrine 4 (6.6%) 6 (4.4%) .50
Intraoperative change in
hemoglobin (mean  SD)
5.5  1.9 5.41  1.9 .76
Lowest intraoperative
hemoglobin (mean  SD)
7  1.5 7.2  1.2 .21
Highest post-CPB re-warming
temperature
36.9  0.86 36.6  0.64 .04*
ARF, Acute renal failure; IABP, intra-aortic balloon pump; CPB, cardiopulmonary
bypass; STS, Society of Thoracic Surgeons; SD, standard deviation. *Significance<.05.
TABLE 5. Conditional logistic regression model: Predictors of acute
renal failure
Odds
ratio
95% Confidence
interval
P
value*
Cardiac catheterization
within 24 h
5.3 1.4–19.0 .01*
Cardiac catheterization
within 24–48 h
0.4 0.1–2.8 .47
Cardiac catheterization
within 48–72 h
3.1 0.8–12.3 .11
Cardiac catheterization
>72 h before
REF REF REF
No. of postoperative vasopressors
(in first 6 h)
1.7 1.2–2.4 .007*
Preoperative ACE inhibitors/ARB 1.0 0.5–2.1 .37
Aprotinin 1.3 0.3–2 .61
Change in hemoglobin 1.0 0.8–1.2 .96
Lowest intraoperative hemoglobin 0.8 0.6–1.1 .23
Highest post-CPB rewarming
temperature (C)
1.4 0.9–2.3 .18
CPB time 1 1.0–1.1 .56
ACE, Angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker;
CPB, cardiopulmonary bypass. REF indicates no effect was estimated, because this
value serves as the reference standard for the covariate’s measure of effect.
*Significance< .05.
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Of these patients, 6% had a major postoperative complica-
tion with an 18% 30-day mortality rate. Similar to patients
described in the literature,1-3,6,23-25 patients with ARF in
this study had significantly worse postoperative outcomes.
Patients with ARF also had longer CPB times, and
therefore CPB time was included in the multivariable
logistic regression to eliminate it as a confounder. They
had higher rates of infection, longer intensive care unitTABLE 4. Postoperative outcomes after valve surgery
ARF
(n ¼ 61) (%)
No ARF
(n ¼ 136) (%)
P
value*
Sepsis 11 (18.0%) 4 (2.9%) <.0001*
Deep sternal wound infection 1 (1.6%) 0 (0) .31
Stroke 7 (11.5%) 10 (7.4%) .34
Reoperation for bleeding or
tamponade
10 (16.4%) 8 (5.9%) .02*
Noncardiac reoperation 14 (23.0%) 5 (3.7%) <.0001*
Gastrointestinal event 13 (21.7%) 2 (1.5%) <.001*
Pneumonia 18 (29.5%) 6 (4.4%) <.001*
Prolonged ventilation 42 (68.3%) 22 (16.2%) <.000*
Length of stay (d, mean SD) 24.3  21.3 8  4.8 <.0001*
ICU stay (h, mean  SD) 384.7  444.3 79.2  72.7 <.0001*
Mortality (30 d) 11 (18.3%) 7 (5.1%) .004*
ICU, Intensive care unit; SD, standard deviation. *Significance< .05.
1014 The Journal of Thoracic and Cardiovascular Surstays, and overall longer hospitalizations (Table 4). Given
the significant postoperative complications associated with
ARF after valve surgery, identifying methods of prevention
of renal injury is imperative.
Preoperative cardiac catheterization is the standard of care
before valve surgery, and many patients commonly undergo
both catheterization and valve surgery sequentially in a sin-
gle hospitalization for convenience. The American College
of Cardiology and American Heart Association Guidelines
recommend preoperative cardiac catheterization before
valve surgery in any man or postmenopausal woman aged
35 years or more and in any premenopausal woman with
risk factors. They also recommend catheterization in mild
to moderate valve disease if there is evidence of angina, is-
chemia, decreased left ventricular function, or overt conges-
tive heart failure.26 Currently, the temporal relationship
between cardiac catheterization and surgery on the develop-
ment of ARF has primary focused on CABG and combina-
tion cardiac procedures. We lack specific insight on
the nature of this relationship for patients undergoing valve
repair and replacement procedures.
In patients undergoing CABG, Medalion and col-
leagues,14 as well as others,13 reported surgery within 5
days of cardiac catheterization was as an independent predic-
tor of postoperative ARF. Ranucci and colleagues15 found
that delaying cardiac surgery more than 24 hours from the
time of cardiac catheterization decreased the incidence of
postoperative ARF by 3-fold. On the other hand, Brown
and colleagues27 suggest in a select population that same-
day coronary angiography may be safe before valve surgery.gery c November 2010
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undergoing valve surgery and collaborates the findings after
CABG and combined cardiac procedures. The timing of car-
diac catheterization was a significant predictor of ARF.
Catheterization within 24 hours of surgery was significantly
greater in patients with ARF than in patients without ARF
(31.2% vs 8.8%, P ¼ .01). The risk of ARF was more
than 5 times higher for patients who underwent cardiac
catheterization within 24 hours of surgery compared with
patients who underwent catheterization more than 72 hours
before surgery (OR, 5.3; CI, 1.9–15.2; P ¼ .004).
Contrast-induced nephropathy after cardiac catheteriza-
tion and ARF after valve surgery have been well described
in the literature. Contrast administration and valve surgery
likely have synergistic effects on the kidney, causing renal
dysfunction. Contrast administration likely decreases the
functional reserve of the kidneys (‘‘first hit’’), making pa-
tients less likely to withstand a ‘‘second hit,’’ which is either
the valve procedure itself or any postoperative complication
such as bleeding or a need for vasopressors. Increasing the
time between cardiac catheterization and valve surgery
may limit this multiple hit phenomenon. When feasible, per-
forming cardiac catheterization more than 24 hours before
the time of valve surgery is recommended.
Notably, the administration of postoperative vasopressors
was significantly associated with the development of ARF
after valve surgery. The use of these agents has been associ-
ated with the development of postoperative renal failure after
cardiac surgery.28-31 However, previous studies have failed
to identify postoperative vasopressor use as a significant
independent predictor of ARF.28,30 In our study, patients
with ARF were more likely to receive norepinephrine and
vasopressin than patients without ARF. Furthermore,
postoperative vasopressor use was found to be predictive
of ARF, with a 2-fold increased risk for every additional
vasopressor given (OR, 1.7; CI, 1.2–2.4; P ¼ .007).
Cardiac performance has been described as one of the crit-
ical factors in the development of ARF after cardiac sur-
gery.31 The conflicting results between our study and
others may be explained by patient selection. Currently it
is ambiguous whether vasopressor use is the cause of ARF
or a marker of severity of illness in these patients. Unlike
other studies, our study controlled for the degree of heart
failure and overall severity of preoperative illness, and the
patients in the ARF and no ARF groups were identical.
Therefore, in our study we concluded that vasopressor
administration is predictive of ARF independently of heart
failure and overall severity of illness in the patient.
Limitations
This is a small retrospective, case-control study, and
therefore it is limited by its inherent biases and inability to
indicate absolute risk. We recognize there are other potential
modifiable risk factors for ARF that were not addressed inThe Journal of Thoracic and Carour analysis. One potential confounder in this study is the
significant difference in postoperative complications be-
tween patients with and without ARF. Patients with ARF
had higher rates of postoperative complications. This may
be the cause of ARF in some patients; however, on the basis
of these data, it is difficult to tease out which came first: ARF
or the other postoperative complications.
ARF was defined on the basis of STS database criteria;
however, they are several other definitions of renal failure
(Risk Injury Failure Loss ESKD/RIFLE/Acute Kidney
Injury Network) that could be used to describe this popula-
tion. However, STS definitions are widely accepted and
followed in our field. The difference of 1.1 and 1.2 was
not significant, although it was close. In a young patient,
that difference might not be of importance, whereas in an
older patient a difference of 0.1 might be significant. How-
ever, in this study our patients were well matched on age
and other comorbidities; therefore, this difference is likely
not significant overall. However, STS definitions are well
established and the definition of ARF is a conservative
one; therefore, we think our conclusions are accurate and
appropriate. We also recognize that it is not always feasible
to delay the time from cardiac catheterization to valve sur-
gery in all patients; however, a concerted effort should be
made.CONCLUSIONS
ARF is a significant complication after heart valve sur-
gery. Cardiac catheterization is often performed less than
24 hours before valve surgery for convenience. However,
we demonstrate that catheterization within 24 hours of valve
surgery is independently associated with the development of
ARF. When feasible, current practice should be adjusted to
ensure that more than 24 hours have passed from the time of
cardiac catheterization to the time of valve surgery.References
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Dr John Byrne (Nashville, Tenn). I have questions about poten-
tial surrogates that you may have perhaps overlooked. What about
these patients just being more complex patients, having bigger
operations? I think the clamp times were longer. They were bigger,
more complex operations. Did they have low cardiac output
syndrome requiring all of those inotropes after surgery, which
was the cause of renal failure, not necessarily the catheterization
24 hours prior?
Dr Hennessy. Yes, as everybody knows, ARF may be a surro-
gate for postoperative low cardiac output syndrome. This may be
the case for some patients. We certainly tried to match for this as
best as we could. Patients were equivalent on preoperative ejection
fraction and their heart failure class, and so we attempted to match
for that as best as we could between those 2 groups. ARF may be
a surrogate for other major adverse events, meaning that it may
just be one of the complications that occur because of some other
reason. This may be true for some patients, and in other patients
ARF may be the cause of some of their complications. This is prob-
ably especially true in patients who undergo dialysis, have higher
rates of infection, and have longer intensive care unit stays.
With regard to that it might relate to the classic question of which
comes first, the chicken or the egg, this is a bit difficult to tease out,
and it is definitely not something that we specifically looked at in
these groups of patients. We know that ARF is one cause of a sig-
nificant amount of morbidity and mortality in these patients, and we
believe that this is at least one simple and effective way that we may
be able to help prevent ARF and perhaps at least lessen some of the
complications after surgery.
Dr Byrne. I ask that, because in our hybrid catheterization lab-
oratory operating room, we routinely catheterize patients, hundreds
of patients, and we just haven’t seen this. Now, it is true that if
a patient sustains a major adverse event that compounds the injury,
he/she is probably more likely to develop renal failure and all these
other complications.
So as a follow-up now, how about a patient with tight aortic ste-
nosis, someone who has really, really tight aortic stenosis and now
requires aortic valve replacement. I know Mike Davidson at the
Brigham is catheterizing them himself just before surgery. Are
you recommending waiting 2448 hours in those patients?
Dr Hennessy. I think I would look at it in 2 different perspec-
tives. In patients with tight aortic stenosis, if they have lived with
their symptoms for weeks, months, and years, maybe 24 hours
won’t make much of a difference for them, but it definitely depends
on the specific patient and how he/she presents. If it is clearly some-
body who presents in an emergency case, we don’t recommend de-
laying surgery. You clearly have to do what is best for the patient.
Our center believes that maybe some of what happens is part of a 2-
hit process to the kidneys. The kidneys might take a first hit with the
contrast load and then a second hit subsequently with undergoing
surgery, and it might be the case that if you combine this together
one time on the table that it diminishes the risk or the kidneys just
take one hit and maybe you don’t have as much renal failure
afterward. That is definitely something to look at in the future
and try to tease out.
Dr Robert Kramer (Portland, Me). Congratulations on an ex-
cellent presentation. Your conclusions are fully supported by work
that our group presented at the STS meeting in January.gery c November 2010
Hennessy et al Acquired Cardiovascular Disease
A
C
DWe use the Acute Kidney Injury Network definition for acute
kidney injury, which has a lower threshold than the STS definition.
We found that when the cardiac surgery admission was separated
from the cardiac catheterization admission, the incidence of acute
kidney injury was reduced by 45%. Short- and long-term survivals
are compromised in patients with acute kidney injury. Your work
may further the opportunity to change a standard of care. We
now encourage our colleagues to separate the surgical admission
from the catheterization admission whenever possible. Of course,
there are times when urgent surgery is compelling and one can’t de-
lay, but there are times, as you mentioned, that you can.
Our analysis did not clearly answer the question as to how long
to delay surgery after cardiac catheterization. What is your recom-
mendation when asked that question?
Dr Hennessy. In this group of patients, and, of course, this is
a retrospective study, so I think further studies should be done in
the future to validate what we found, there should be at least 24
hours before patients proceed to surgery. Now, whether a greater
amount of time might help the patients more and reduce their injury
even greater, I think that is something that needs to be studied, but
at this time I think at least 24 hours should be separated between the
time of catheterization to the time of surgery.
Dr Harold Lazar (Boston, Mass). I have 2 questions to ask. I
noticed that you chose to look at renal function by measuring cre-
atinine, and if you look at the patients who did and did not have re-
nal failure postoperatively, the difference was approximately 1.1
versus 1.3 and the P value was .06. But I wonder whether you
looked at glomerular filtration rate, which is a more sensitive indi-
cator of renal function. You might have seen a difference between
those patients who developed renal failure postoperatively regard-
ing their preoperative glomerular filtration rate.
Dr Hennessy. That is a good point. Clearly there are many dif-
ferent ways of setting acute kidney injury, and glomerular filtration
rate is one of those ways, and that might be one of the limitations of
our study. However, according to the other variables we looked at,
we focused on STS definitions, and so we wanted to focus on an
STS definition of renal failure.
Now, clearly the difference was 1.1 to 1.2, I believe, and it was
close to statistical significance. In a younger patient, that might not
mean as much and maybe in an older patient it does, and I think that
is something to study in the future and attempt to have a better def-
inition of renal failure.
Dr Lazar. I think youmaywant to go back and look at those glo-
merular filtration rates, because they probably will be different.
My second question relates to the type of catheterization that was
done. At our institution when we catheterize somebody before
valve surgery, it is to see whether they have any coronary lesions,
and we are only shooting the coronaries with a limited amount of
dye, not doing a ventriculogram or attempting to cross the valves.
So what type of catheterization was done, how much dye was used,The Journal of Thoracic and Cardo you actually know the amount of dye, and could you correlate
those patients who developed renal failure with the amount of
dye that they received preoperatively?
DrHennessy.With regard to the type of catheterization that was
done, we took all patients and did not specifically do a subanalysis
of what type they underwent. Originally one of our main questions
was also the amount of contrast and the type of dye that were used
and whether or not that also affects ARF after surgery. Unfortu-
nately, that was difficult because a retrospective study is needed
to find those answers within the patient’s records, and that is some-
thing we are looking in the future to work on as a prospective study
to see if that makes a difference.
Dr Ali Khoynezhad (Omaha, Neb). I’d like to follow up on one
of the questions that was just brought up by a previous discussant,
namely, the importance of using estimated glomerular filtration as
a more sensitive measurement for renal function before and after
any procedure. There are also the RIFLE criteria based on the
Acute Dialysis Quality Initiative Group. This is the foundation
that internationally recognized the consensus definition for ARF,
endorsed by nephrologists. So that is something I suggest you
may want to consider for future studies, so we can compare apples
to apples.
I wonder if you can tell us also any protocols involving perioper-
ative hydration of patients undergoing heart catheterization. Typi-
cal patients with heart disease are usually diuresed rather than
given any fluid, which may be helpful for the right ventricle and
the heart but counterproductive for the kidneys.
DrHennessy. For our patients, it clearly depended on the type of
patient and the degree of heart failure. As you said, many of these
patients are diuresed before surgery. So I think it was patient spe-
cific in terms of how much hydration these patients received before
surgery.
Dr Lawrence Cohn (Boston, Mass). I have one last question
that I want to ask in a socioeconomic vein. There is a huge national
push by hospital administrators to have patients come in the same
day, have the operation, and save a lot of preoperative days. Are the
hospital administrators at the University of Virginia comfortable
with the decision now that you are changing your protocol, or are
you changing your protocol for admission catheterization surgery?
Dr Hennessy. Since the results of this study, we have changed
our protocol and our administration is in full support. One of the
things about the University of Virginia is that our patients come
from a wide distance because the hospital covers such a wide
area. So many of our patients come from 3 to 5 hours away, and
for them, not only for the administration but for the patient, it would
be a convenience for them to have their cardiac catheterization
within the same hospitalization of their surgery. But we believe
our administration has been supportive of us in delaying this time
period, and in the future we will look to see that this will reduce
the amount of renal failure after surgery in these patients.diovascular Surgery c Volume 140, Number 5 1017
